Table 1 Number of frames, patients and types of CE device per group, which was divided in training/validation (90% of patients, including a threefold cross validation) vs. test group (10% of remaining).

From: Automated detection and classification of cervical and anal squamous cancer precursors using deep learning and multidevice colposcopy

 

Frames (n)

Patients (n)

Devices (n)

Regions (n)

LSIL (n)

HSIL (n)

Fold 1

24,729

151

3

2

12,968

11,781

Fold 2

24,729

150

3

2

12,968

11,781

Fold 3

24,729

152

3

2

12,968

11,781

Test set

8250

148

3

2

4323

3927

Back to article page